Literature DB >> 2029081

Cytogenetic and molecular evaluation of clinically aggressive esthesioneuroblastoma.

V L Castañeda1, M S Cheah, V A Saldivar, C M Richmond, R T Parmley.   

Abstract

We report a 16-year-old boy with esthesioneuroblastoma that presented with a unilateral tumor extending to the maxillary sinus and periorbital region. Despite initial therapy with gross resection, 5,682 cGy to the tumor bed and chemotherapy, the patient subsequently had a rapid local recurrence with distant metastases. Immunocytochemical, ultrastructural, cytogenetic, and molecular techniques were performed to determine if this tumor was biologically similar to childhood neuroblastoma. Urinary excretion of vanillylmandelic acid (VMA) and homovanillic acid (HVA) were markedly elevated. Chromogranin and neuron specific enolase immunostaining of tumor cells was positive, as seen in neuroblastoma. Electron microscopic studies showed cells that were closely packed and connected by occasional cell junctions. The cell cytoplasm contained moderate amounts of filaments and microtubules. Numerous electron dense granules were observed; however, these granules lacked distinct nucleoids and generally reacted strongly for acid phosphatase, indicating a lysosomal rather than a secretory function. Tumor cells contained near-pseudotetraploid chromosomes, with all chromosomes represented at least three times, and chromosome 5 was present in multiples of eight. Clonal structural abnormalities included 2q+ and 5q+ and multiple double minutes. Northern blot analysis revealed both c-myc and N-myc expression; however, N-myc amplification was not demonstrated, and c-myc expression appeared increased, unlike cases of rapidly progressive neuroblastoma. These results suggest that despite biologic similarities to neuroblastoma in catecholamine excretion and some ultrastructural features, molecular genetic abnormalities differ in this comparatively aggressive case of estesioneuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029081     DOI: 10.1097/00043426-199121000-00015

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  7 in total

Review 1.  Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastoma.

Authors:  Vafi Salmasi; Adam Schiavi; Zev A Binder; Jacob Ruzevick; Brent A Orr; Peter C Burger; Douglas W Ball; Ari M Blitz; Wayne M Koch; Masaru Ishii; Gary L Gallia
Journal:  Head Neck       Date:  2015-04-06       Impact factor: 3.147

Review 2.  The genomics and epigenetics of olfactory neuroblastoma: A systematic review.

Authors:  Raman Preet Kaur; Evgeny Izumchenko; Dukagjin M Blakaj; Nikol Mladkova; Matt Lechner; Thomas L Beaumont; Charalampos S Floudas; Gary L Gallia; Nyall R London
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-07

3.  Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.

Authors:  Ronald Koschny; Heidrun Holland; Jaromir Sykora; Hande Erdal; Wolfgang Krupp; Manfred Bauer; Ulrike Bockmuehl; Peter Ahnert; Jürgen Meixensberger; Wolfgang Stremmel; Henning Walczak; Tom M Ganten
Journal:  J Neurooncol       Date:  2009-09-20       Impact factor: 4.130

4.  Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Authors:  M E Carney; R C O'Reilly; B Sholevar; O I Buiakova; L D Lowry; W M Keane; F L Margolis; J L Rothstein
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

Review 5.  Review of skull base surgery approaches: with special reference to pediatric patients.

Authors:  J D Kennedy; S J Haines
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Authors:  Glen J Weiss; Winnie S Liang; Tyler Izatt; Shilpi Arora; Irene Cherni; Robert N Raju; Galen Hostetter; Ahmet Kurdoglu; Alexis Christoforides; Shripad Sinari; Angela S Baker; Raghu Metpally; Waibhav D Tembe; Lori Phillips; Daniel D Von Hoff; David W Craig; John D Carpten
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

Review 7.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.